Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Crinetics Pharmaceuticals Inc. · Carcinoid Syndrome · Carcinoid
Phase 3
Recruiting
141
2026-06
Industry sponsor intelligence
Crinetics Pharmaceuticals Inc.Clinical Pipeline.
Lead-sponsor view of Crinetics Pharmaceuticals Inc.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 3
- Recruiting
- 1
- Active
- 0
- Completed
- 2
- Results posted
- 2
- Avg enrollment
- 63
Pipeline overview
Programs by phase and activity.
Velocity
Crinetics Pharmaceuticals Inc. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
3phase labels
Early Phase 10
Phase 10
Phase 22
Phase 31
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Lanreotide → | 3 | 0 | 2 | 1 | 0 | 1 |
| Octreotide → | 3 | 0 | 2 | 1 | 0 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc. · Carcinoid Syndrome · Carcinoid
Phase 2
Completed
36
2026-03
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
Crinetics Pharmaceuticals Inc. · Acromegaly
Phase 2
Completed
13
2025-03
Search sponsor records
All Crinetics Pharmaceuticals Inc. studies.
This page groups studies where Crinetics Pharmaceuticals Inc. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
3 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT07087054Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenJun 25, 2026NCT05361668Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromeMar 19, 2026NCT03792555A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)Mar 17, 2025